Skip to main content
. 2018 May 21;15(5):e1002571. doi: 10.1371/journal.pmed.1002571

Fig 1. Schematic representation of the transitions between start of follow-up (healthy), first cardiometabolic disease, cardiometabolic multimorbidity, and mortality.

Fig 1